FHTX
Price
$5.11
Change
+$0.13 (+2.61%)
Updated
Dec 20, 04:59 PM (EDT)
75 days until earnings call
PBYI
Price
$2.75
Change
-$0.02 (-0.72%)
Updated
Dec 20, 04:59 PM (EDT)
68 days until earnings call
Ad is loading...

FHTX vs PBYI

Header iconFHTX vs PBYI Comparison
Open Charts FHTX vs PBYIBanner chart's image
Foghorn Therapeutics
Price$5.11
Change+$0.13 (+2.61%)
Volume$3.29K
CapitalizationN/A
Puma Biotechnology
Price$2.75
Change-$0.02 (-0.72%)
Volume$4.46K
CapitalizationN/A
FHTX vs PBYI Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. PBYI commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and PBYI is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (FHTX: $5.14 vs. PBYI: $2.76)
Brand notoriety: FHTX and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 283% vs. PBYI: 81%
Market capitalization -- FHTX: $285.75M vs. PBYI: $135.24M
FHTX [@Biotechnology] is valued at $285.75M. PBYI’s [@Biotechnology] market capitalization is $135.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while PBYI’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 6 bearish.
  • PBYI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а -3.02% price change this week, while PBYI (@Biotechnology) price change was -4.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 06, 2025.

PBYI is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($286M) has a higher market cap than PBYI($135M). FHTX YTD gains are higher at: -20.310 vs. PBYI (-36.374). PBYI has higher annual earnings (EBITDA): 49.4M vs. FHTX (-98.53M). FHTX has more cash in the bank: 267M vs. PBYI (96.7M). FHTX has less debt than PBYI: FHTX (39.1M) vs PBYI (86.4M). PBYI has higher revenues than FHTX: PBYI (244M) vs FHTX (25.5M).
FHTXPBYIFHTX / PBYI
Capitalization286M135M212%
EBITDA-98.53M49.4M-199%
Gain YTD-20.310-36.37456%
P/E RatioN/A5.91-
Revenue25.5M244M10%
Total Cash267M96.7M276%
Total Debt39.1M86.4M45%
FUNDAMENTALS RATINGS
PBYI: Fundamental Ratings
PBYI
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
23
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FHTXPBYI
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 23 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 5 days ago
82%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATHDX28.880.51
+1.80%
American Century Heritage R6
TMIFX10.720.17
+1.61%
Transamerica Mid Cap Growth R4
IRLSX82.470.75
+0.92%
Voya Russell Large Cap Growth Idx Port S
IPMIX21.330.18
+0.85%
Voya Index Plus MidCap Port I
SHPCX12.67N/A
N/A
Saratoga Health & Biotechnology C

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with NTLA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+3.21%
NTLA - FHTX
45%
Loosely correlated
+1.08%
CRSP - FHTX
43%
Loosely correlated
+0.83%
ABOS - FHTX
42%
Loosely correlated
+2.22%
RLAY - FHTX
42%
Loosely correlated
-2.23%
CCCC - FHTX
41%
Loosely correlated
+2.60%
More

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with ABCL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
-0.90%
ABCL - PBYI
35%
Loosely correlated
+4.80%
ARVN - PBYI
35%
Loosely correlated
+3.65%
MDGL - PBYI
34%
Loosely correlated
+5.21%
AURA - PBYI
33%
Loosely correlated
+1.23%
VNDA - PBYI
33%
Loosely correlated
+3.13%
More